the hsp90 inhibitor nvp-auy922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved dna damage一半抑制剂nvp-auy922 radiosensitizes废除的同源重组导致有丝分裂条目未解决的dna损伤.pdfVIP

the hsp90 inhibitor nvp-auy922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved dna damage一半抑制剂nvp-auy922 radiosensitizes废除的同源重组导致有丝分裂条目未解决的dna损伤.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
the hsp90 inhibitor nvp-auy922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved dna damage一半抑制剂nvp-auy922 radiosensitizes废除的同源重组导致有丝分裂条目未解决的dna损伤

The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage 1. 1 . 1 2 3 Shane Zaidi , Martin McLaughlin * , Shreerang A. Bhide , Suzanne A. Eccles , Paul Workman , 4 5 1,4 Christopher M. Nutting , Robert A. Huddart , Kevin J. Harrington 1Targeted Therapy Team, Institute of Cancer Research, Chester Beatty Laboratories, London, United Kingdom, 2 Tumour Biology and Metastasis Team, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, United Kingdom, 3 Signal Transduction and Molecular Pharmacology Team, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, United Kingdom, 4 The Royal Marsden Hospital, London, United Kingdom, 5 The Royal Marsden Hospital, Sutton, United Kingdom Abstract Background: Heat shock protein 90 (HSP90) is a molecular chaperone responsible for the conformational maintenance of a number of client proteins that play key roles in cell cycle arrest, DNA damage repair and apoptosis following radiation. HSP90 inhibitors exhibit antitumor activity by modulating the stabilisation and activation of HSP90 client proteins. We sought to evaluate NVP-AUY922, the most potent HSP90 inhibitor yet reported, in preclinical radiosensitization studies. Principal Findings: NVP-AUY922 potently radiosensitized cells in vitro at low nanomolar concentrations with a concurrent depletion of radioresistance-linked client proteins. Radiosensitization by NVP-AUY922 was verified for the first time

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档